N4 Pharma Plc (AIM:N4P)
London · Delayed Price · Currency is GBP · Price in GBX 0.5000
-0.0250 (-4.76%)
Mar 5, 2026, 3:10 PM GMT
N4 Pharma Market Cap
N4 Pharma has a market cap or net worth of 4.37 million as of March 5, 2026. Its market cap has increased by 92.49% in one year.
Market Cap
4.37M
Enterprise Value
2.64M
Revenue
7.07K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
Market Cap Chart
Since May 3, 2017, N4 Pharma's market cap has decreased from 4.57M to 4.37M, a decrease of -4.43%. That is a compound annual growth rate of -0.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 4.37M | - |
| Dec 31, 2025 | 4.37M | 110.82% |
| Dec 31, 2024 | 2.07M | -9.28% |
| Dec 29, 2023 | 2.28M | -47.18% |
| Dec 30, 2022 | 4.32M | -46.33% |
| Dec 31, 2021 | 8.06M | -46.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haleon | 34.64B |
| Hikma Pharmaceuticals | 2.75B |
| HUTCHMED (China) | 1.75B |
| Allergy Therapeutics | 696.58M |
| Animalcare Group | 186.42M |
| Shield Therapeutics | 96.59M |
| Venture Life Group | 84.41M |
| ECO Animal Health Group | 68.44M |